NYSE:RNRRenaissanceRe Stock Price, Forecast & News

RenaissanceRe's stock was trading at $155.96 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RNR stock has increased by 7.6% and is now trading at $167.86. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RenaissanceRe in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for RenaissanceRe.

RenaissanceRe is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for RenaissanceRe.

RenaissanceRe Holdings Ltd. (NYSE:RNR) released its earnings results on Wednesday, May, 6th. The insurance provider reported $0.76 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $3.87 by $3.11. The insurance provider had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.03 billion. RenaissanceRe had a net margin of 9.16% and a return on equity of 6.06%. The company's revenue for the quarter was up 36.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.60 EPS. View RenaissanceRe's earnings history.

RenaissanceRe announced a quarterly dividend on Tuesday, May 19th. Stockholders of record on Monday, June 15th will be paid a dividend of $0.35 per share on Tuesday, June 30th. This represents a $1.40 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date of this dividend is Friday, June 12th. View RenaissanceRe's dividend history.

7 brokers have issued twelve-month price targets for RenaissanceRe's stock. Their forecasts range from $158.00 to $200.00. On average, they anticipate RenaissanceRe's stock price to reach $186.43 in the next twelve months. This suggests a possible upside of 11.1% from the stock's current price. View analysts' price targets for RenaissanceRe.

News articles about RNR stock have trended very negative recently, InfoTrie reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. RenaissanceRe earned a coverage optimism score of -3.5 on InfoTrie's scale. They also gave media coverage about the insurance provider a news buzz of 9.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news aboutRenaissanceRe.

RenaissanceRe saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 598,200 shares, a decrease of 18.0% from the April 30th total of 729,600 shares. Based on an average daily volume of 408,000 shares, the short-interest ratio is presently 1.5 days. Approximately 1.4% of the company's shares are sold short. View RenaissanceRe's Current Options Chain.

Some companies that are related to RenaissanceRe include Everest Re Group (RE), Alleghany (Y), Reinsurance Group of America (RGA), Enstar Group (ESGR), Greenlight Capital Re (GLRE), Maiden (MHLD) and Partnerre (PRE.PH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other RenaissanceRe investors own include Verizon Communications (VZ), Xilinx (XLNX), Advanced Micro Devices (AMD), Home Depot (HD), Exxon Mobil (XOM), Taiwan Semiconductor Mfg. (TSM), Zoetis (ZTS), Fortinet (FTNT), NVIDIA (NVDA) and Universal Display (OLED).

RenaissanceRe trades on the New York Stock Exchange (NYSE) under the ticker symbol "RNR."

RenaissanceRe's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.17%), State Street Corp (4.77%), Capital World Investors (4.28%), Janus Henderson Group PLC (2.74%), TimesSquare Capital Management LLC (2.58%) and Capital International Investors (2.18%). Company insiders that own RenaissanceRe stock include Aditya Dutt, Henry Klehm III, Ian D Branagan, Jonathan Paradine, Kevin Odonnell, Ross Curtis and Sean G Brosnan. View institutional ownership trends for RenaissanceRe.

RNR stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, BlackRock Inc., APG Asset Management N.V., Federated Hermes Inc., NWQ Investment Management Company LLC, Janus Henderson Group PLC, Wellington Management Group LLP, and First Trust Advisors LP. Company insiders that have sold RenaissanceRe company stock in the last year include Aditya Dutt, Ian D Branagan, Jonathan Paradine, Kevin Odonnell, and Sean G Brosnan. View insider buying and selling activity for RenaissanceRe.

RNR stock was purchased by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Wells Fargo & Company MN, ARGA Investment Management LP, Alliancebernstein L.P., APG Asset Management N.V., APG Asset Management N.V., Victory Capital Management Inc., and Capital World Investors. View insider buying and selling activity for RenaissanceRe.

Shares of RNR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of RNR stock can currently be purchased for approximately $167.86.

RenaissanceRe has a market capitalization of $7.39 billion and generates $4.20 billion in revenue each year. The insurance provider earns $748.80 million in net income (profit) each year or $9.13 on an earnings per share basis.

The official website for RenaissanceRe is www.renre.com.

RenaissanceRe's mailing address is RENAISSANCE HOUSE 12 CROW LANE, PEMBROKE D0, HM 19. The insurance provider can be reached via phone at 441-295-4513 or via email at [email protected]